 | Alpine Immune Sciences, Inc. | |||
| NGM : ALPN || Location: United States | ||||
$64.62+0.05 (+0.08%) |
1.77 M | 64.54 - 64.65 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 4.742 M |
| March 28, 2024 | 5.285 M |
| March 15, 2024 | 5.611 M |
| Feb. 29, 2024 | 4.428 M |
| Feb. 15, 2024 | 4.030 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.34 | 0.12 | 135.05% |
| 09/30/2023 | -0.34 | -0.24 | 29.64% |
| 06/30/2023 | -0.38 | -0.27 | 29.28% |
| 03/31/2023 | -0.38 | -0.28 | 25.93% |
| 12/31/2022 | -0.27 | -0.41 | -49.96% |
ALPN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 65.561M | Shares Float | 44.945M |
| Short Float | 4.742M | Market Cap | 4236.55M |
| Institution ownership | 91.10% | Insider ownership | 4.645% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.64 | Forward EPS | -1.89 |